Neuberger Berman Canada’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Neuberger Berman Canada's PFE Position: Q3 2017 in Review
Neuberger Berman Canada increased its Pfizer (PFE) stake by 5.2% in Q3 2017, buying an estimated $675K and bringing the position to 427,789 shares worth $14.5M. The position accounts for 2.67% of the portfolio, ranked #2.
Neuberger Berman Canada first reported a position in PFE in Q3 2013 and has held it in 15 quarters since. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.
- Neuberger Berman Canada held 427,789 shares of Pfizer worth $14.5M as of Q3 2017.
- Neuberger Berman Canada bought 21,011 Pfizer shares in Q3 2017, an estimated $675K.
- Pfizer made up 2.67% of Neuberger Berman Canada's portfolio in Q3 2017, its #2 holding.
- Neuberger Berman Canada first reported a position in Pfizer in Q3 2013 and has held it in 15 quarters since.
- 2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.
Based on Neuberger Berman Canada's 13F filing for Q3 2017, filed 3 Nov 2017.